Tiziana Life Sciences Ltd (TLSA) Gamma Exposure (GEX) & Greeks
Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.
Tiziana Life Sciences Ltd (TLSA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $89.1M, listed on NASDAQ, employing roughly 9 people, carrying a beta of 0.42 to the broader market. Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. Led by Ivor R. Elrifi, public since 2018-11-20.
Snapshot as of May 15, 2026.
- Spot Price
- $1.40
- Net Gamma
- $906
- Net Delta
- -$82.7K
- Net Vega
- -$495
- Gamma Concentration
- 0.87
As of May 15, 2026, Tiziana Life Sciences Ltd (TLSA) has positive net gamma exposure of $906 under the standard dealer-hedging convention. Net delta exposure is -$82.7K. Positive GEX means dealers are net long gamma: they buy into dips and sell into rallies, damping realized volatility and often causing price to pin near heavy open-interest strikes.
TLSA Strategy Sizing in the Current GEX Regime
Tiziana Life Sciences Ltd is in a positive dealer-gamma regime ($906). Net dealer delta of -$82.7K sets the size of the directional hedging flow that fires as spot moves. In this regime, mean-reverting strategies fit the regime: credit spreads, iron condors, covered calls near established ranges. Realized volatility tends to undershoot implied during positive-gamma stretches, supporting the short-vol structures. The gamma-flip level - the spot price at which net dealer gamma changes sign - is the most actionable anchor for sizing: through-flip moves trigger qualitatively different hedging behavior than within-regime moves, so risk-defined structures sized to the current spot may not stay sized correctly if a flip is near.
Learn how gamma exposure is reported and how to read the data →
Frequently asked TLSA gamma exposure (gex) & greeks questions
- What is the current TLSA gamma exposure (GEX)?
- As of May 15, 2026, Tiziana Life Sciences Ltd (TLSA) net gamma exposure is positive at $906 under the standard dealer-hedging convention. Net dealer delta exposure is -$82.7K. GEX aggregates the gamma sitting on dealer books across all listed strikes and expirations.
- Is TLSA in positive or negative dealer gamma right now?
- TLSA is currently in positive dealer gamma. Dealers net long gamma buy underlying weakness and sell into rallies to maintain delta-neutrality, which dampens realized volatility and tends to pin price near heavy open-interest strikes.
- What does TLSA GEX tell options traders?
- GEX is a regime indicator: positive-gamma regimes favor mean-reverting strategies (premium-selling near established ranges); negative-gamma regimes favor momentum and breakout strategies. The same options-strategy structure can be appropriate or inappropriate depending on the dealer-gamma regime, so reading the sign and magnitude of net GEX before sizing positions is standard practice.